148 related articles for article (PubMed ID: 23581641)
21. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
Hyvönen M; Saraste M
EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of inhibiting Bruton's tyrosine kinase, (BTK).
Vassilev AO; Uckun FM
Curr Pharm Des; 2004; 10(15):1757-66. PubMed ID: 15180538
[TBL] [Abstract][Full Text] [Related]
23. Activation mechanism and steady state kinetics of Bruton's tyrosine kinase.
Dinh M; Grunberger D; Ho H; Tsing SY; Shaw D; Lee S; Barnett J; Hill RJ; Swinney DC; Bradshaw JM
J Biol Chem; 2007 Mar; 282(12):8768-76. PubMed ID: 17264076
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis.
Kong W; Deng W; Sun Y; Huang S; Zhang Z; Shi B; Chen W; Tang X; Yao G; Feng X; Sun L
Clin Rheumatol; 2018 Jan; 37(1):43-49. PubMed ID: 28612243
[TBL] [Abstract][Full Text] [Related]
25. TEC family kinases in health and disease--loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK.
Hussain A; Yu L; Faryal R; Mohammad DK; Mohamed AJ; Smith CI
FEBS J; 2011 Jun; 278(12):2001-10. PubMed ID: 21518255
[TBL] [Abstract][Full Text] [Related]
26. A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.
Eifert C; Wang X; Kokabee L; Kourtidis A; Jain R; Gerdes MJ; Conklin DS
Genes Chromosomes Cancer; 2013 Oct; 52(10):961-75. PubMed ID: 23913792
[TBL] [Abstract][Full Text] [Related]
27. Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma.
Yang Y; Shi J; Gu Z; Salama ME; Das S; Wendlandt E; Xu H; Huang J; Tao Y; Hao M; Franqui R; Levasseur D; Janz S; Tricot G; Zhan F
Cancer Res; 2015 Feb; 75(3):594-604. PubMed ID: 25589346
[TBL] [Abstract][Full Text] [Related]
28. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members.
Müller S; Sideras P; Smith CI; Xanthopoulos KG
Oncogene; 1996 Nov; 13(9):1955-64. PubMed ID: 8934542
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells.
Feldhahn N; Río P; Soh BN; Liedtke S; Sprangers M; Klein F; Wernet P; Jumaa H; Hofmann WK; Hanenberg H; Rowley JD; Müschen M
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13266-71. PubMed ID: 16141323
[TBL] [Abstract][Full Text] [Related]
30. Development of a Selective Labeling Probe for Bruton's Tyrosine Kinase Quantification in Live Cells.
Chen J; Wang X; He F; Pan Z
Bioconjug Chem; 2018 May; 29(5):1640-1645. PubMed ID: 29652138
[TBL] [Abstract][Full Text] [Related]
31. Screening and Characterization of Allosteric Small Molecules Targeting Bruton's Tyrosine Kinase.
Kueffer LE; Lin DY; Amatya N; Serrenho J; Joseph RE; Courtney AH; Andreotti AH
Biochemistry; 2024 Jan; 63(1):94-106. PubMed ID: 38091504
[TBL] [Abstract][Full Text] [Related]
32. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
[TBL] [Abstract][Full Text] [Related]
33. Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain.
Mohamed AJ; Yu L; Bäckesjö CM; Vargas L; Faryal R; Aints A; Christensson B; Berglöf A; Vihinen M; Nore BF; Smith CI
Immunol Rev; 2009 Mar; 228(1):58-73. PubMed ID: 19290921
[TBL] [Abstract][Full Text] [Related]
34. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
[TBL] [Abstract][Full Text] [Related]
35. Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling.
Bender AT; Gardberg A; Pereira A; Johnson T; Wu Y; Grenningloh R; Head J; Morandi F; Haselmayer P; Liu-Bujalski L
Mol Pharmacol; 2017 Mar; 91(3):208-219. PubMed ID: 28062735
[TBL] [Abstract][Full Text] [Related]
36. The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review.
Liang C; Tian D; Ren X; Ding S; Jia M; Xin M; Thareja S
Eur J Med Chem; 2018 May; 151():315-326. PubMed ID: 29631132
[TBL] [Abstract][Full Text] [Related]
37. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
38. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
[TBL] [Abstract][Full Text] [Related]
39. ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library.
Gustafsson MO; Mohammad DK; Ylösmäki E; Choi H; Shrestha S; Wang Q; Nore BF; Saksela K; Smith CI
PLoS One; 2017; 12(4):e0174909. PubMed ID: 28369144
[TBL] [Abstract][Full Text] [Related]
40. Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis.
Uckun FM
Biochem Pharmacol; 1998 Sep; 56(6):683-91. PubMed ID: 9751072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]